Alteral Therapeutics ApS 13D and 13G filings for NORDICUS PARTNERS CORP.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-12-10 2:04 pm Sale | 2024-11-12 | 13D | NORDICUS PARTNERS CORP. NORD | Alteral Therapeutics ApS | 5,296,131 30.810% | -7,356,148 (-58.14%) | Filing |
| 2024-11-13 11:02 am Unchanged | 2024-05-14 | 13D | NORDICUS PARTNERS CORP. NORD | Alteral Therapeutics ApS | 12,652,279 13.000% | 0 (Unchanged) | Filing |
| 2024-11-05 3:10 pm Unchanged | 2024-05-14 | 13D | NORDICUS PARTNERS CORP. NORD | Alteral Therapeutics ApS | 12,652,279 13.000% | 0 (Unchanged) | Filing |
| 2024-06-05 4:49 pm Purchase | 2024-05-14 | 13D | NORDICUS PARTNERS CORP. NORD | Alteral Therapeutics ApS | 12,652,279 13.000% | 12,652,279 (New Position) | Filing |